FDA Seeks More Input on Drug Supply Chain Pilot
The Food and Drug Administration is reopening the period for comments from industry on the development of its "supply chain" pilot program under the Drug Supply Chain Security Act, it said (here). The agency is interested in “issues related to…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
utilizing the product identifier for product tracing, improving the technical capabilities of the supply chain, and identifying system attributes that are necessary to implement the requirements established” under the 2013 law (see 13121725), it said. FDA specifically requested information on using the product identifier for tracing a product, the technical capabilities of each sector of the supply chain to use the unique identifier for tracing, and "system attributes that are necessary to implement the requirements established under the DSCSA." Comments are now due April 30, 2018.